VCM
REUN

Vivaldi Capital Management’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Vivaldi Capital Management’s Portfolio REUN Stock Details REUN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,000
Closed -$20.7K – 213
2023
Q1 		$20.7K Hold
30,000
– – 0.01% 202
2022
Q4 		$40.1K Hold
30,000
– – 0.01% 239
2022
Q3 		$56K Buy
+30,000
New +$107K 0.02% 218

Other funds holding REUN

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
OPOWM
One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return
KLCM
KG&L Capital Management Saint Francisville, Louisiana $139M AUM 26.97% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $1.83B AUM 18.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vivaldi Capital Management's REUN Position: Q2 2023 in Review

Vivaldi Capital Management sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q2 2023, closing a stake of 30,000 shares — an estimated $20.7K sold.

Vivaldi Capital Management first reported a position in REUN in Q3 2022 and held it in 3 quarters. The position peaked at $56K in Q3 2022. 21 funds tracked by Wall St. Rank hold REUN as of Q2 2023.

  • Vivaldi Capital Management reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q2 2023 after selling out during the quarter.
  • Vivaldi Capital Management sold 30,000 Reunion Neuroscience Inc. Common Shares shares in Q2 2023, an estimated $20.7K.
  • Vivaldi Capital Management first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2022 and held it in 3 quarters.
  • Vivaldi Capital Management's Reunion Neuroscience Inc. Common Shares position peaked at $56K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q2 2023.

Based on Vivaldi Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.